Inventor · disambiguated record
Taeyoung Yoon
Also filed as: YOON TAEYOUNG
30 granted patents·16 pending applications·179 citations·filing 1994–2023
96Inventor score
Files withNEUROGEN CORP22DONG-A SOCIO HOLDINGS CO LTD7DONG A ST CO LTD2SLOAN KETTERING INST CANCER2TAEYOUNG E&T CO LTD2
Top patents by PatentIndex Score
46 records- 0188US7304059B2Substituted quinazolin-4-ylamine analoguesNEUROGEN CORP·Filed 2006·Granted Dec 4, 2007·10 cites·58 claims
- 0285US6353103B1Isoquinolinamine and phthalazinamine derivatives: corticotropin-releasing factor receptor CRF1 specific ligandsNEUROGEN CORP·Filed 2000·Granted Mar 5, 2002·11 cites·29 claims
- 0383US8338591B23-aryl-5,6-disubstituted pyridazinesYOON TAEYOUNG·Filed 2005·Granted Dec 25, 2012·14 cites·1 claims
- 0480US10913730B2Heteroaryl compounds and their use as Mer inhibitorsDONG A SOCIO HOLDINGS CO LTD·Filed 2017·Granted Feb 9, 2021·2 cites·14 claims
- 0579US6953801B2Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analoguesNEUROGEN CORP·Filed 2002·Granted Oct 11, 2005·11 cites·30 claims
- 0678US7566712B2Biaryl piperazinyl-pyridine analoguesNEUROGEN CORP·Filed 2004·Granted Jul 28, 2009·11 cites·59 claims
- 0778US7148225B2Substituted biaryl amides as C5A receptor modulatorsNEUROGEN CORP·Filed 2004·Granted Dec 12, 2006·7 cites·28 claims
- 0877US7223778B25-substituted-2-arylpyridinesNEUROGEN CORP·Filed 2002·Granted May 29, 2007·15 cites·29 claims
- 0976US8222248B2Organic compoundsSUNG MOO JE·Filed 2007·Granted Jul 17, 2012·5 cites·11 claims
- 1076US6583169B2N-phenyl benzimidazolecarboxamide and N-phenyl indolecarboxamide derivativesNEUROGEN CORP·Filed 2001·Granted Jun 24, 2003·6 cites·19 claims
- 1174US6995161B2Substituted arylpyrazinesNEUROGEN CORP·Filed 2001·Granted Feb 7, 2006·7 cites·91 claims
- 1272US7179807B25-substituted-2-arylpyrazinesNEUROGEN CORP·Filed 2003·Granted Feb 20, 2007·7 cites·15 claims
- 1369US6281237B1N-phenyl benzimidazolecarboxamide and N-phenyl indolecarboxamide derivativesNEUROGEN CORP·Filed 2000·Granted Aug 28, 2001·7 cites·67 claims
- 1467US6114530AIsoquinolinamine and phthalazinamine derivatives: corticotropin-releasing factor receptor CRF1 specific ligandsNEUROGEN CORP·Filed 1998·Granted Sep 5, 2000·17 cites·22 claims
- 1565USD789484SWater ionizerTAEYOUNG E&T CO LTD·Filed 2016·Granted Jun 13, 2017·11 cites·1 claims
- 1664US12195446B2Heteroaryl compounds and their use as therapeutic drugsDONG A SOCIO HOLDINGS CO LTD·Filed 2020·Granted Jan 14, 2025·0 cites·4 claims
- 1764US10947215B2Heteroaryl compounds and their use as therapeutic drugsDONG A SOCIO HOLDINGS CO LTD·Filed 2018·Granted Mar 16, 2021·0 cites·12 claims
- 1863US6495686B2Pyrimido [4,5,b]indolizine derivatives and aza analogues thereof; CRF1 specific ligandsNEUROGEN CORP·Filed 2001·Granted Dec 17, 2002·1 cites·9 claims
- 1962US12378224B2Heteroaryl compounds and their use as Mer inhibitorsDONG A SOCIO HOLDINGS CO LTD·Filed 2020·Granted Aug 5, 2025·0 cites·10 claims
- 2061US9834550B2Pyridopyrimidinone compounds for modulating the catalytic activity of histone lysine demethylases (KDMs)DONG-A SOCIO HOLDINGS CO LTD·Filed 2015·Granted Dec 5, 2017·1 cites·5 claims
- 2161US6858637B2Substituted biaryl amides as C5a receptor modulatorsNEUROGEN CORP·Filed 2003·Granted Feb 22, 2005·1 cites·20 claims
- 2260US5622958AEnediyne quinone imines and methods of preparation and use thereofSLOAN KETTERING INST CANCER·Filed 1994·Granted Apr 22, 1997·24 cites·45 claims
- 2360US2008015183A1Substituted quinazolin-4-ylamine analoguesNEUROGEN CORP·Filed 2007·Application pending·0 cites
- 2456US7241765B2Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analoguesNEUROGEN CORP·Filed 2006·Granted Jul 10, 2007·0 cites·44 claims
- 2553US7202250B2Substituted arylpyrazinesNEUROGEN CORP·Filed 2005·Granted Apr 10, 2007·0 cites·16 claims
- 2652USD788877SWater ionizerTAEYOUNG E&T CO LTD·Filed 2016·Granted Jun 6, 2017·6 cites·1 claims
- 2752US2007225287A1Substituted ArylpyrazinesYOON TAEYOUNG·Filed 2007·Application pending·0 cites
- 2850US6440969B2Certain isoquinolinamine and phthalazinamine derivatives: corticotropin-releasing factor receptor CRF1 specific ligandsNEUROGEN CORP·Filed 2001·Granted Aug 27, 2002·0 cites·18 claims
- 2950US2025161271A1Pharmaceutical composition for treating cancer, comprising anticancer agent and novel compound having inhibitory activity with respect to prostaglandin e2 receptorsKANAPH THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3050US2007043056A15-Substituted-2-arylpyrazinesNEUROGEN CORP·Filed 2006·Application pending·0 cites
- 3150US2011092505A1Organic compoundsBURGIS ROBIN·Filed 2009·Application pending·0 cites
- 3248US10125118B2Heteroaryl compounds and their use as therapeutic drugsDONG A SOCIO HOLDINGS CO LTD·Filed 2016·Granted Nov 13, 2018·0 cites·15 claims
- 3347US2023150970A1Aminopyrimidine derivatives and their use as aryl hydrocarbon receptor modulatorsDONG A ST CO LTD·Filed 2021·Application pending·0 cites
- 3446US6235752B1Isoquinolinamine and phthalazinamine derivatives which interact with CRF receptorsNEUROGEN CORP·Filed 1997·Granted May 22, 2001·4 cites·14 claims
- 3546US2007043049A1Substituted heterocyclic diarylamine analoguesNEUROGEN CORP·Filed 2004·Application pending·0 cites
- 3646US2012142685A1Organic compoundsDOBLER MARKUS ROLF·Filed 2008·Application pending·0 cites
- 3745US2023147257A1Pyridopyrimidinone derivatives and their use as aryl hydrocarbon receptor modulatorsDONG A ST CO LTD·Filed 2021·Application pending·0 cites
- 3843US2006100245A1Substituted biphenyl-4-carboxylic acid arylamide analoguesNEUROGEN CORP·Filed 2003·Application pending·0 cites
- 3942US2008161344A1Melanin Concentrating Hormone Receptor Ligands: Substituted Tetrahydroisoquinoline AnaloguesSTEENSTRA CHERYL K·Filed 2005·Application pending·0 cites
- 4041US2016145247A1Aminomethyl-Biaryl Derivatives Complement Factor D inhibitors and uses thereofBELANGER DAVID B·Filed 2014·Application pending·0 cites
- 4140US2006009456A1Aryl-substituted piperazine derivativesHUTCHINSON ALAN J·Filed 2005·Application pending·0 cites
- 4238US2003055037A1Benzimidazole and indole derivatives as CRF receptor modulatorsFiled 2001·Application pending·0 cites
- 4337US2002072521A15-substituted arylpyrimidinesFiled 2001·Application pending·0 cites
- 4436US6194574B1Pyrido[2,3-b]indolizine derivatives and aza analogues thereof: CRF1 specific ligandsNEUROGEN CORP·Filed 1999·Granted Feb 27, 2001·1 cites·9 claims
- 4531US2017057955A1Pyridopyrimidinone Compounds for Modulating the Catalytic Activity of Histone Lysine Demethylases (KDMs)DONG-A SOCIO HOLDINGS CO LTD·Filed 2016·Application pending·0 cites
- 4628US6020341AEnediyne quinone imines and methods of preparation and use thereofSLOAN KETTERING INST CANCER·Filed 1995·Granted Feb 1, 2000·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Taeyoung Yoon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →